Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: P01 AI097092
NIAID NIH HHS
Grant: R01 AI145870
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201400008C
National Institute of Allergy and Infectious Diseases
Grant: R01-AI146101
National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00051
NIAID NIH HHS
Grant: R01 AI146101
National Institute of Allergy and Infectious Diseases
Grant: AI07647
NIAID NIH HHS
Grant: T32 AI007647
National Institute of Allergy and Infectious Diseases
Grant: 5P01AI097092
National Institutes of Health
Grant: 5T32AI007647-15
TRAINING PROGRAM IN MECHANISMS OF VIRUS-HOST INTERACTIONS
National Institutes of Health
Grant: 5R01AI146101-05
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
National Institutes of Health
Grant: 5P01AI097092-04
Monoclonal Antibody Technology Core
National Institutes of Health
Grant: 3R01AI145870-02S1
Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals